Olmesartan Tablets 40mg

Olmesartan Tablets 40 mg – Reliable Blood Pressure Management by Apindex Pharma

Olmesartan Tablets 40 mg are widely prescribed for the treatment of high blood pressure (hypertension) and help reduce the risk of serious cardiovascular complications such as heart attack, stroke, and kidney damage. Olmesartan belongs to a class of medicines known as angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels and improving blood flow throughout the body.

As a trusted pharmaceutical manufacturer and exporter, Apindex Pharma offers high-quality Olmesartan Tablets 40 mg that comply with international quality standards. The company is recognized globally for its commitment to delivering safe, effective, and affordable pharmaceutical products to healthcare markets worldwide.

Uses of Olmesartan Tablets 40 mg

Olmesartan Tablets 40 mg are primarily used for:

• Treatment of high blood pressure (hypertension)

• Reduction of cardiovascular risks associated with uncontrolled blood pressure

• Protection of kidney function in patients with hypertension

• Long-term management of heart and vascular health

• Prevention of complications such as stroke and heart attack

How Olmesartan 40 mg Works

Olmesartan blocks the action of angiotensin II, a natural substance that causes blood vessels to narrow. By preventing this effect, the medication allows blood vessels to relax and widen, resulting in lower blood pressure and improved circulation.

Side Effects of Olmesartan Tablets 40 mg

Dizziness or lightheadedness

• Headache

• Fatigue

• Nausea

• Back pain

• Mild diarrhea

Olmesartan Tablets 40 mg Manufacturer and Exporter

Apindex Pharma is a trusted manufacturer and exporter of Olmesartan Tablets 40 mg, supplying high-quality antihypertensive medicines to global markets. With a strong focus on quality assurance, regulatory compliance, and customer satisfaction, Apindex Pharma continues to be a preferred pharmaceutical partner for businesses seeking reliable cardiovascular medications.